The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third‐degree burn injury
Akbar Ahmad; Gabor Olah; David N Herndon; Csaba Szabo
Author Information: Department of Anesthesiology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.